Amendment and Mail Process Complete

EMISAR

Emisar Pharma Services LLC

Amendment and Mail Process Complete

Trademark Snap Shot Amendment & Mail Processing Stylesheet
(Table presents the data on Amendment & Mail Processing Complete)

OVERVIEW

SERIAL NUMBER 90795780 FILING DATE 06/25/2021
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE SERVICE MARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY KNIGHT, TROY FRANK
L.O. ASSIGNED 107

PUB INFORMATION

RUN DATE 07/02/2022
PUB DATE N/A
STATUS 661-RESPONSE AFTER NON-FINAL-ACTION-ENTERED
STATUS DATE 07/01/2022
LITERAL MARK ELEMENT EMISAR

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) YES 1 (b) YES 1 (b) NO
44D NO 44D NO 44D NO
44E NO 44E NO 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK YES
LITERAL MARK ELEMENT EMISAR
MARK DRAWING CODE 4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME Emisar Pharma Services LLC
ADDRESS Corporation Trust Center, 1209 Orange St
Wilmington, DE 19801
ENTITY 16-LTD LIAB CO
CITIZENSHIP Delaware

GOODS AND SERVICES

INTERNATIONAL CLASS 035
          DESCRIPTION TEXT Business consulting and management services in the fields of prescription drugs and cost management of health care; Negotiating contracts with manufacturers of pharmaceuticals to obtain discounts on the purchase of their goods; Business consulting related to clinical trials; Pharmaceutical cost management services and drug utilization review services; Business administration of pharmacy reimbursement programs and services; Business research and analytics services, including providing analytics to facilitate pharmaceutical innovation; Providing a portal for pharmaceutical analytics, namely, providing a website featuring business information on pharmaceutical analytics
INTERNATIONAL CLASS 036
          DESCRIPTION TEXT Financial administration of pharmacy reimbursement programs and services
INTERNATIONAL CLASS 042
          DESCRIPTION TEXT Technical consulting and research in the field of pharmaceutical studies; Pharmaceutical product evaluation; Providing a portal for pharmaceutical analytics, namely, providing a website featuring medical research and scientific research information on pharmaceutical analytics
INTERNATIONAL CLASS 044
          DESCRIPTION TEXT Providing a portal for pharmaceutical analytics, namely, providing a website featuring medical information on pharmaceutical analytics

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 035 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 036 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 042 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 044 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
07/01/2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED 015
06/30/2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE 014
06/30/2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED 013
05/23/2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED 012
05/23/2022 GNRT O NON-FINAL ACTION E-MAILED 011
05/23/2022 CNRT R NON-FINAL ACTION WRITTEN 010
04/19/2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED 009
04/19/2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE 008
04/19/2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED 007
04/06/2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED 006
04/06/2022 GNRT F NON-FINAL ACTION E-MAILED 005
04/06/2022 CNRT R NON-FINAL ACTION WRITTEN 004
03/16/2022 DOCK D ASSIGNED TO EXAMINER 003
09/09/2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 002
06/29/2021 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Joseph V. Myers III
CORRESPONDENCE ADDRESS Joseph V. Myers III
SEYFARTH SHAW LLP
1075 PEACHTREE ST. N.E., #2500
ATLANTA GA 30309
DOMESTIC REPRESENTATIVE NONE

Amendment and Mail Process Complete [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed